Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2015-09-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ankle Robotics After Stroke
NCT04594837
The General Use of Robots in Stroke Recovery: the Anklebot
NCT02249832
Ankle Robotics Training After Stroke
NCT01337960
TREAT Foot Drop After Stroke With Ankle Robot
NCT04137809
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
NCT01072032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators have developed an adaptive anklebot controller that detects gait cycle sub-events for precise timing of graded robotics assistance to enable deficit severity-adjusted ankle motor learning in the context of walking. The investigators' pilot findings show that 6 weeks treadmill training with anklebot (TMR) timed to assist swing phase dorsiflexion only is more effective than treadmill alone (TM) to improve free-walking swing dorsiflexion at foot strike, floor-walking speed, and the benefits are retained at 6 weeks post-training. Notably, swing-phase TMR training improved paretic leg push-off, and reduced center-of-pressure sway on standing balance, indicating potential benefits to other elements of gait and balance, beyond those robotically targeted toward foot drop.
This randomized study investigates the hypothesis that 6 weeks TMR is more effective to improve durably gait biomechanics, static, and dynamic balance, and mobility function in chronic stroke survivors with dorsiflexion deficits, compared to TM alone. Aims are to determine the compare effectiveness of 6 weeks TMR vs. TM alone on:
1. Independent gait function indexed by gait velocity, swing-phase DF (dorsiflexion), terminal stance push-off.
2. Balance function indexed by measures of postural sway (CoP), asymmetric loading in quiet standing, peak paretic A-P forces in non-paretic gait initiation, and standardized scales for balance and fall risk.
3. Long-term mobility outcomes, assessed by repeated measures of all key gait and balance outcomes at 6 weeks and 3 months after formal training cessation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treadmill+anklebot
This group will receive gait training on a treadmill while wearing the anklebot with the adaptive control system.
Treadmill plus anklebot
This intervention employs the use of the adaptive anklebot control system to complement treadmill exercise training over a 6-week intervention period.
Treadmill only
This group will receive gait training on a treadmill, without use of the anklebot.
Treadmill only
This intervention employs the use of a treadmill for gait exercise training over a 6-week intervention period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treadmill plus anklebot
This intervention employs the use of the adaptive anklebot control system to complement treadmill exercise training over a 6-week intervention period.
Treadmill only
This intervention employs the use of a treadmill for gait exercise training over a 6-week intervention period
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residual hemiparesis of the lower extremity that includes symptoms of foot drop
* Capable of ambulating on a treadmill with handrail support
* Already completed all conventional physical therapy
* Adequate language and cognitive function to provide informed consent and participate in testing and training
Exclusion Criteria
* Unstable angina
* Recent (\< 3 months) myocardial infarction
* Congestive heart failure (NYHA category II or higher)
* Hemodynamic valvular dysfunction
* Hypertension that is a contraindication for a bout of treadmill training (\>160/100 mmHg on two assessments)
* Medical history of:
* Recent hospitalization (\< 3 months) for any serious condition leading to significant bed-rest or reduction in mobility function
* Symptomatic peripheral arterial occlusive disease
* Orthopedic or chronic pain conditions restricting exercise
* Pulmonary failure requiring oxygen
* Uncompensated renal failure
* Active cancer
* Neurological history and exam consistent with:
* Dementia
* Receptive or global aphasia that confounds testing and training, operationally defined as unable to follow 2-point commands
* Non-stroke neurological disorder restricting exercise (e.g. Parkinson's Syndrome, myopathy)
* Untreated major depression
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven J Kittner
Role: PRINCIPAL_INVESTIGATOR
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N1699-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.